$200 million raised for the launch of a new biopharmaceutical company to reduce excessive drug prices

Rebecca Moody Harris is a CPA and CFO with over eighteen years of progressive financial experience. For the last twelve years, she has served the healthcare industry in CFO and executive leadership roles. Her experience ranges from large corporations to start-ups in the private sector, and Rebecca specializes in Mergers and Acquisitions, Private Equity fundraising, and computer information systems.